|
 |
|
|
|
| |
|
|
|
|
| Table 4. Receipt of antiretroviral therapy by HIV-infected women and HIV-exposed infants, by timing of receipt and year of infant’s birth, 2000–2003—24 areas conducting enhanced perinatal surveillance in the United States and dependent areas |
|
|
|
|
View PDF
|
|
 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
| |
Year of infant's birth |
|
Cumulative
total |
| |
2000 |
|
2001 |
|
2002 |
|
2003 |
|
| Receipt of antiretroviral therapy |
No. |
% |
|
No. |
% |
|
No. |
% |
|
No. |
% |
|
No. |
% |
| Prenatal period |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Yes |
2,730 |
80 |
|
2,390 |
81 |
|
1,627 |
82 |
|
1,361 |
83 |
|
8,108 |
81 |
| No |
527 |
15 |
|
441 |
15 |
|
243 |
12 |
|
207 |
13 |
|
1,418 |
14 |
| Unknown |
165 |
5 |
|
132 |
4 |
|
117 |
6 |
|
68 |
4 |
|
482 |
5 |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Intrapartum period |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Yes |
1,856 |
79 |
|
1,812 |
80 |
|
1,606 |
83 |
|
1,391 |
85 |
|
6,665 |
81 |
| No |
391 |
17 |
|
352 |
15 |
|
277 |
14 |
|
205 |
13 |
|
1,225 |
15 |
| Unknown |
108 |
5 |
|
112 |
5 |
|
55 |
3 |
|
40 |
2 |
|
315 |
4 |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Neonatal period |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Yes |
3,162 |
92 |
|
2,741 |
93 |
|
1,875 |
94 |
|
1,559 |
95 |
|
9,337 |
93 |
| No |
175 |
5 |
|
121 |
4 |
|
69 |
3 |
|
35 |
2 |
|
400 |
4 |
| Unknown |
85 |
2 |
|
101 |
3 |
|
43 |
2 |
|
42 |
3 |
|
271 |
3 |
| Totala |
3,422 |
|
|
2,963 |
|
|
1,987 |
|
|
1,636 |
|
|
10,008 |
|
|
|
|
| Note. Because of rounding, column percentages may not total to 100 percent. The numbers of women receiving antiretroviral therapy prenatally and intrapartum are not mutually exclusive. |
|
|
|
| a |
Total includes 1,803 women with unknown treatment status. |
| |
Next: Table 5 |
|
|
|
|
|
|
|
